High-degree atrioventricular heart block induced by pramipexole

References (1)

1. Alyan O, Ozdemir O, Soylu M, Demir AD, Topaloğlu S, Kaçmaz F, et al. Classification of patients with complete atrioventricular block according to etiological, demographic and clinical features and pacemaker needs. Anatol J Cardiol 2003; 3: 203-10. [Article in Turkish] 2. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol 1996; 78: 187-96. [Crossref] 3. Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al.; American Academy of Sleep Medicine. The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012; 35: 1039-62. [Crossref] 4. Cherian S, Tomas P, Sreekrishnan TP, Gireesh KP. Pramipexole Induced Complete Heart Block: A Case Report. Journal of Pharmaceutical Research 2015: 89. [Crossref] 5. Renoux C, Dell’Aniello S, Brophy JM, Suissa S. Dopamine agonist use and the risk of heart failure. Pharmacoepidemiol Drug Saf 2012; 21: 34-41. [Crossref] 6. Mokhles MM, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, et al. The risk of new onset heart failure associated with dopamine agonist use in Parkinson’s disease. Pharmacol Res 2012; 65: 358-64. [Crossref]